Therefore, we speculate that RuvBL1 overexpression might be associated with TRAIL-resistance in NSCLC, and downregulation of RuvBL1 probably sensitizes lung cancer cells to TRAIL-induced apoptosis. Here, RUVBL1 is linked to lung cancer.